128 related articles for article (PubMed ID: 24691679)
1. Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.
Peters RP; Van Ramshorst MS; Struthers HE; McIntyre JA
Eur J Pediatr; 2014 Sep; 173(9):1245-8. PubMed ID: 24691679
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
[TBL] [Abstract][Full Text] [Related]
3. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
Moore RD; Wong WM; Keruly JC; McArthur JC
AIDS; 2000 Feb; 14(3):273-8. PubMed ID: 10716503
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.
Hulgan T; Haas DW; Haines JL; Ritchie MD; Robbins GK; Shafer RW; Clifford DB; Kallianpur AR; Summar M; Canter JA
AIDS; 2005 Sep; 19(13):1341-9. PubMed ID: 16103764
[TBL] [Abstract][Full Text] [Related]
5. Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients.
Dave JA; Lambert EV; Badri M; West S; Maartens G; Levitt NS
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):284-9. PubMed ID: 21602696
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
Evans D; Takuva S; Rassool M; Firnhaber C; Maskew M
J Neurovirol; 2012 Jun; 18(3):162-71. PubMed ID: 22528477
[TBL] [Abstract][Full Text] [Related]
7. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection.
Cepeda JA; Wilks D
AIDS; 2000 Feb; 14(3):332-3. PubMed ID: 10716516
[No Abstract] [Full Text] [Related]
8. Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study.
Osler M; Stead D; Rebe K; Meintjes G; Boulle A
HIV Med; 2010 Feb; 11(2):121-9. PubMed ID: 19702629
[TBL] [Abstract][Full Text] [Related]
9. Peripheral neuropathy during stavudine-didanosine antiretroviral therapy.
Reliquet V; Mussini JM; Chennebault JM; Lafeuillade A; Raffi F
HIV Med; 2001 Apr; 2(2):92-6. PubMed ID: 11737385
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
11. Effects of a reduced dose of stavudine on the incidence and severity of peripheral neuropathy in HIV-infected adults in South Africa.
Pahuja M; Grobler A; Glesby MJ; Karim F; Parker G; Gumede S; Naidoo K
Antivir Ther; 2012; 17(4):737-43. PubMed ID: 22414588
[TBL] [Abstract][Full Text] [Related]
12. Peripheral neuropathy in HIV-infected children attending care and treatment clinic, at Muhimbili National Hospital, Dar es Salaam: a cross sectional study.
Amiji IA; Naburi HE; Kija E; Mumburi LP
BMC Neurol; 2021 Aug; 21(1):314. PubMed ID: 34388988
[TBL] [Abstract][Full Text] [Related]
13. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
Wadley AL; Cherry CL; Price P; Kamerman PR
J Pain Symptom Manage; 2011 Apr; 41(4):700-6. PubMed ID: 21145196
[TBL] [Abstract][Full Text] [Related]
14. Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study.
Pillay P; Wadley AL; Cherry CL; Karstaedt AS; Kamerman PR
J Peripher Nerv Syst; 2019 Dec; 24(4):304-313. PubMed ID: 31587421
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy in HIV: prevalence and risk factors.
Evans SR; Ellis RJ; Chen H; Yeh TM; Lee AJ; Schifitto G; Wu K; Bosch RJ; McArthur JC; Simpson DM; Clifford DB
AIDS; 2011 Apr; 25(7):919-28. PubMed ID: 21330902
[TBL] [Abstract][Full Text] [Related]
16. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team.
Simpson DM; Katzenstein DA; Hughes MD; Hammer SM; Williamson DL; Jiang Q; Pi JT
AIDS; 1998 Dec; 12(18):2425-32. PubMed ID: 9875580
[TBL] [Abstract][Full Text] [Related]
17. HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM
Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathy in HIV patients on antiretroviral therapy: Does it impact function?
Dudley MT; Borkum M; Basera W; Wearne N; Heckmann JM
J Neurol Sci; 2019 Nov; 406():116451. PubMed ID: 31521960
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda.
Tumusiime DK; Venter F; Musenge E; Stewart A
BMC Public Health; 2014 Dec; 14():1306. PubMed ID: 25526665
[TBL] [Abstract][Full Text] [Related]
20. Peripheral neuropathy in children on stauvudine therapy.
Sankhyan N; Lodha R; Sharma S; Menon PR; Choudhary A; Kabra SK; Gulati S
Indian J Pediatr; 2015 Feb; 82(2):136-9. PubMed ID: 24874810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
